Young-Woo KIM

Full Name
Young-Woo Kim
Nationality
Korea
Position
Director of Research Institute
Organization
National Cancer Center
Brief Bio
Dr. Young-Woo Kim is a director of the National Cancer Center Institute, in Korea. For more than 25 years, he has been a surgeon, researcher, and professor in the Gastric cancer field. Dr. Kim's journey began at Seoul National University School of Medicine, where he earned his undergraduate and doctoral degrees in Surgery. He honed his skills during his residency at Seoul National University Hospital and completed a fellowship in the Department of General Surgery. His dedication to service led him to a three-year stint as a flight surgeon in the ROK Air Force. In 1997, Dr. Kim embarked on his faculty career at Ewha Womans University. Since September 2002, he has been a key member of the Department of Gastric Cancer at the National Cancer Center Korea, a leading cancer hospital in the country. His leadership roles within the National Cancer Center include Head of the Center for Gastric Cancer, Chief of the Gastric Branch at the Research Institute, Chief of Clinical and Translation Research Division, and Head of the Center for Cancer Detection and Prevention. He is now a professor at the Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy. His work has focused on innovative surgical techniques, translational research, telemedicine, and medical device development. Dr. Kim has performed over 5,000 gastrectomy procedures and authored 357 original articles, including one in the Journal of the American Medical Association(JAMA). He has also been serving as subject editor(GI) of Surgical Endoscopy since 2022. As a former president of SMIT (2018) he announced 'Seoul Declaration: A Manifesto for Ethical Medical Technology' with SMIT participants. He is currently serving as president of The Korean Society of Endo-Laparoscopic & Robotic Surgery (KSERS), a board member of the Korean Cancer Society, and a member of the IARC(International Agency for Research on Cancer affiliated with WHO) Scientific Council. Recently, as the director of the National Cancer Center Research Institute and chairman of the National Cancer Control Planning Board, he has taken the initiative in planning a national research project to revitalize cancer research in Korea and is participating in establishing a national health and medical technology promotion plan. In addition, he is trying to establish a cooperative relationship to promote joint research on cancer globally.
Specialty
- Surgical oncology (gastric cancer) - Translational research (proteogenomics and drug development) - Medical engineering for surgical device development - Patient blood management - Medical ethics on AI
Education
Seoul National University College of Medicine (1988) Seoul National University Postgraduate School, M.Sc (1992) Seoul National University Postgraduate School, Ph D (1998)
Honors/Awards
- Civil Merit Medal(2023)/ Minister of Health and Welfare Minister’s Award(2016) for the Advancement of Healthcare and Medical industry - Hamchoon Dong-A Medical Academic Award(2018), which was established by the Seoul National University Alumni Association to inspire the research motivation of alumni professors - Doosan Yonkang Academic Award (2017), the best science research award in the Korea Surgical Society
Publication
- Effect of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction vs Total Gastrectomy on Hemoglobin Level and Vitamin B12 Supplementation in Upper-Third Early Gastric Cancer A Randomized Clinical Trial: JAMA NETWORK OPEN. 6(2):e2256004~ (2023) - Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients With Early Gastric Cancer: A Randomized Clinical Trial: JOURNAL OF CLINICAL ONCOLOGY. 40(21):2342~2351 (2022) - Laparoscopy-Assisted versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: Results from a Randomized Phase II Multicenter Clinical Trial (COACT 1001): Annals of Surgery. 267(4):638~645 (2017) - Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomized controlled trial.: Lancet. 379(9813):315~321 (2012) - Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial: Annals of Surgery. 248:721~727 (2008)

20 October 2023 (Friday)

Time Session
11:40
12:30
Charles Lin Moderator
Yi-Shing LEU Moderator
Intl. Conference Hall, Show-Chwan 1F